Vikrant Sahasrabuddhe
Faculty Member
Last active: 10/3/2015

Profile

Dr. Sahasrabuddhe is now based as Program Director in the Division of Cancer Prevention at the National Cancer Institute (NCI), National Institutes of Health (NIH).

Publications

Featured publications are shown below:

  1. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane-Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci E, Graubard BI, Hollenbeck AR, Hou L, Jacobs EJ, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, Purdue MP, Rosenberg L, Schairer C, Sesso HD, Sigurdson AJ, Wactawski-Wende J, Zeleniuch-Jacquotte A, Campbell PT, McGlynn KA (2015) Cancer Prev Res (Phila) 8(12): 1156-62
    › Primary publication · 26391917 (PubMed) · PMC4704448 (PubMed Central)
  2. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP (2015) J Acquir Immune Defic Syndr 70(1): e20-6
    › Primary publication · 26322673 (PubMed) · PMC4791059 (PubMed Central)
  3. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ (2015) BMC Cancer : 541
    › Primary publication · 26205980 (PubMed) · PMC4512016 (PubMed Central)
  4. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, Alavanja MC, Beane-Freeman LE, Boggs DA, Buring JE, Chan AT, Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, Hollenbeck AR, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, Poynter JN, Purdue MP, Robien K, Schairer C, Sesso HD, Sigurdson AJ, Zeleniuch-Jacquotte A, Wactawski-Wende J, Campbell PT, McGlynn KA (2015) Cancer Epidemiol Biomarkers Prev 24(9): 1398-406
    › Primary publication · 26126626 (PubMed) · PMC4576990 (PubMed Central)
  5. The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. Katundu K, Bateman AC, Pfaendler KS, Mwanahamuntu MH, Kapambwe S, Vermund SH, Sahasrabuddhe VV, Msadabwe SC, Stringer JS, Parham GP, Chibwesha CJ (2015) J Low Genit Tract Dis 19(4): 301-6
    › Primary publication · 26125097 (PubMed) · PMC4583804 (PubMed Central)
  6. Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up. McCree R, Giattas MR, Sahasrabuddhe VV, Jolly PE, Martin MY, Usdan SL, Kohler C, Lisovicz N (2015) Oncologist 20(6): 621-6
    › Primary publication · 25926351 (PubMed) · PMC4571774 (PubMed Central)
  7. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Chi BH, Stringer JS, Sankaranarayanan R, Sahasrabuddhe VV (2015) PLoS One 10(4): e0122169
    › Primary publication · 25885821 (PubMed) · PMC4401717 (PubMed Central)
  8. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project. McGlynn KA, Sahasrabuddhe VV, Campbell PT, Graubard BI, Chen J, Schwartz LM, Petrick JL, Alavanja MC, Andreotti G, Boggs DA, Buring JE, Chan AT, Freedman ND, Gapstur SM, Hollenbeck AR, Hou L, King LY, Koshiol J, Linet M, Palmer JR, Poynter JN, Purdue M, Robien K, Schairer C, Sesso HD, Sigurdson A, Wactawski-Wende J, Zeleniuch-Jacquotte A (2015) Br J Cancer 112(7): 1266-72
    › Primary publication · 25742475 (PubMed) · PMC4385955 (PubMed Central)
  9. Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink. McGlynn KA, Hagberg K, Chen J, Graubard BI, London WT, Jick S, Sahasrabuddhe VV (2015) J Natl Cancer Inst 107(4)
    › Primary publication · 25722350 (PubMed) · PMC4351398 (PubMed Central)
  10. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M (2015) J Natl Cancer Inst 107(3)
    › Primary publication · 25650316 (PubMed) · PMC4326307 (PubMed Central)
  11. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL (2014) Virol J : 202
    › Primary publication · 25481842 (PubMed) · PMC4279793 (PubMed Central)
  12. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C, Pfaendler KS, Mkumba G, Mudenda V, Kapambwe S, Vermund SH, Hicks ML, Stringer JS, Chi BH (2010) HIV Ther 4(6): 703-722
    › Primary publication · 25419240 (PubMed) · PMC4237284 (PubMed Central)
  13. Statin use and risk of hepatocellular carcinoma in a U.S. population. McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Yood MU, Alford SH (2014) Cancer Epidemiol 38(5): 523-7
    › Primary publication · 25113938 (PubMed) · PMC4188715 (PubMed Central)
  14. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes. Hagberg KW, McGlynn KA, Sahasrabuddhe VV, Jick S (2014) Br J Cancer 111(9): 1710-7
    › Primary publication · 25093492 (PubMed) · PMC4453721 (PubMed Central)
  15. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ (2014) J Acquir Immune Defic Syndr 67(2): 212-5
    › Primary publication · 24977474 (PubMed) · PMC4162769 (PubMed Central)
  16. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE (2014) J Clin Microbiol 52(8): 2892-7
    › Primary publication · 24899025 (PubMed) · PMC4136172 (PubMed Central)
  17. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014) J Clin Virol 60(4): 414-7
    › Primary publication · 24881489 (PubMed) · PMC4146457 (PubMed Central)
  18. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JSA, Parham GP (2014) Int J Gynaecol Obstet 126(1): 88-89
    › Primary publication · 24810795 (PubMed) · PMC4123629 (PubMed Central)
  19. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2014) J Infect Dis 210(3): 448-55
    › Primary publication · 24569064 (PubMed) · PMC4110458 (PubMed Central)
  20. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP (2013) Vaccine : F32-46
    › Primary publication · 24331746 (PubMed) · PMC4144870 (PubMed Central)
  21. Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks. Godfrey CC, Michelow PM, Godard M, Sahasrabuddhe VV, Darden J, Firnhaber CS, Wetherall NT, Bremer J, Coombs RW, Wilkin T, A5282 Study Team (2013) Am J Clin Pathol 140(6): 881-9
    › Primary publication · 24225757 (PubMed) · PMC4017200 (PubMed Central)
  22. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014) J Clin Microbiol 52(1): 187-92
    › Primary publication · 24197879 (PubMed) · PMC3911475 (PubMed Central)
  23. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP (2013) PLoS One 8(9): e74607
    › Primary publication · 24058599 (PubMed) · PMC3776830 (PubMed Central)
  24. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD (2013) PLoS One 8(8): e72565
    › Primary publication · 23977318 (PubMed) · PMC3745470 (PubMed Central)
  25. Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N (2013) J Infect Dis 208(11): 1768-75
    › Primary publication · 23908478 (PubMed) · PMC3814839 (PubMed Central)
  26. Response. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2013) J Natl Cancer Inst 105(9): 668- 71
    › Primary publication · 23767058 (PubMed) · PMC4399434 (PubMed Central)
  27. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2013) Int J Cancer 133(9): 2172-81
    › Primary publication · 23588935 (PubMed) · PMC4238230 (PubMed Central)
  28. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2012) J Natl Cancer Inst 104(23): 1808-14
    › Primary publication · 23197492 (PubMed) · PMC3514167 (PubMed Central)
  29. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N (2013) J Infect Dis 207(3): 392-401
    › Primary publication · 23162133 (PubMed) · PMC3537447 (PubMed Central)
  30. Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. Sahasrabuddhe VV, Sherman ME (2012) J Natl Cancer Inst 104(22): 1698-701
    › Primary publication · 23104325 (PubMed) · PMC3529599 (PubMed Central)
  31. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE (2012) AIDS 26(17): 2185-92
    › Primary publication · 23018436 (PubMed) · PMC4144865 (PubMed Central)
  32. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Sahasrabuddhe VV, Shiels MS, McGlynn KA, Engels EA (2012) Cancer 118(24): 6226-33
    › Primary publication · 22736272 (PubMed) · PMC3965349 (PubMed Central)
  33. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV (2012) PLoS One 7(6): e38731
    › Primary publication · 22723879 (PubMed) · PMC3378535 (PubMed Central)
  34. Fertility drugs and the risk of breast and gynecologic cancers. Brinton LA, Sahasrabuddhe VV, Scoccia B (2012) Semin Reprod Med 30(2): 131-45
    › Primary publication · 22549713 (PubMed) · PMC4106369 (PubMed Central)
  35. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, Smith JS, Jiang CQ, Mei RB, Wang XG, Li ZA, Qiao YL (2012) Asian Pac J Cancer Prev 13(1): 91-6
    › Primary publication · 22502720 (PubMed) · PMC3809115 (PubMed Central)
  36. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH (2012) Cancer Prev Res (Phila) 5(1): 11-7
    › Primary publication · 22158053 (PubMed) · PMC3586242 (PubMed Central)
  37. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Sahasrabuddhe VV, Luhn P, Wentzensen N (2011) Future Microbiol 6(9): 1083-98
    › Primary publication · 21958146 (PubMed) · PMC3809085 (PubMed Central)
  38. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD (2011) PLoS One 6(5): e20183
    › Primary publication · 21673791 (PubMed) · PMC3103539 (PubMed Central)
  39. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP (2011) PLoS Med 8(5): e1001032
    › Primary publication · 21610859 (PubMed) · PMC3096609 (PubMed Central)
  40. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM (2012) Int J Cancer 130(1): 234-40
    › Primary publication · 21387289 (PubMed) · PMC3516675 (PubMed Central)
  41. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Pfaendler K, Parham G (2010) Glob Health Promot 17(2 Suppl): 47-50
    › Primary publication · 20595342 (PubMed) · PMC4123628 (PubMed Central)
  42. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS (2010) J Low Genit Tract Dis 14(3): 167-73
    › Primary publication · 20592550 (PubMed) · PMC3809081 (PubMed Central)
  43. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Bratcher LF, Sahasrabuddhe VV (2010) Infect Agent Cancer : 8
    › Primary publication · 20462441 (PubMed) · PMC2881893 (PubMed Central)
  44. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM (2010) PLoS One 5(1): e8634
    › Primary publication · 20072610 (PubMed) · PMC2798747 (PubMed Central)
  45. HPV screening for cervical cancer in rural India. Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP (2009) N Engl J Med 361(3): 305; author reply 306
    › Primary publication · 19610158 (PubMed) · PMC4123656 (PubMed Central)
  46. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Li AH, Phanuphak N, Sahasrabuddhe VV, Chaithongwongwatthana S, Vermund SH, Jenkins CA, Shepherd BE, Teeratakulpisarn N, van der Lugt J, Avihingsanon A, Ruxrungtham K, Shikuma C, Phanuphak P, Ananworanich J (2009) Sex Transm Infect 85(7): 503-7
    › Primary publication · 19525263 (PubMed) · PMC3875384 (PubMed Central)
  47. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP (2009) AIDS 23(6): N1-5
    › Primary publication · 19279439 (PubMed) · PMC2747794 (PubMed Central)
  48. Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle. Joshi SN, Das S, Thakar M, Sahasrabuddhe V, Kumar BK, Callahan M, Mauck C (2008) J Low Genit Tract Dis 12(4): 293-9
    › Primary publication · 18820544 (PubMed) · PMC4123683 (PubMed Central)
  49. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP (2008) Bull World Health Organ 86(8): D-E
    › Primary publication · 18797604 (PubMed) · PMC2649457 (PubMed Central)
  50. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP (2008) Gynecol Oncol 110(3): 402-7
    › Primary publication · 18556050 (PubMed) · PMC2745977 (PubMed Central)
  51. Building global health through a center-without-walls: the Vanderbilt Institute for Global Health. Vermund SH, Sahasrabuddhe VV, Khedkar S, Jia Y, Etherington C, Vergara A (2008) Acad Med 83(2): 154-64
    › Primary publication · 18303361 (PubMed) · PMC2564795 (PubMed Central)
  52. The future of HIV prevention: control of sexually transmitted infections and circumcision interventions. Sahasrabuddhe VV, Vermund SH (2007) Infect Dis Clin North Am 21(1): 241-57, xi
    › Primary publication · 17502238 (PubMed) · PMC2700301 (PubMed Central)
  53. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP (2007) Br J Cancer 96(9): 1480-3
    › Primary publication · 17437020 (PubMed) · PMC2360194 (PubMed Central)
  54. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH (2006) Gynecol Oncol 103(3): 1017-22
    › Primary publication · 16875716 (PubMed) · PMC2748907 (PubMed Central)
  55. Double jeopardy: HIV and cervical cancer in Indian women. Sahasrabuddhe V, Makhija S (2005) Int J Gynecol Cancer 15(1): 1-3
    › Primary publication · 15670289 (PubMed) · PMC2837929 (PubMed Central)
  56. Patient-led partner referral in a district hospital based STD clinic. Sahasrabuddhe VV, Gholap TA, Jethava YS, Joglekar NS, Brahme RG, Gaikwad BA, Wankhede AK, Mehendale SM (2002) J Postgrad Med 48(2): 105-8
    › Primary publication · 12215690 (PubMed)